BRUKER CORP

Bruker Corporation develops, manufactures, and distributes high-performance scientific instruments and analytical and diagnostic solutions. These products enable customers to explore life and materials at microscopic, molecular, and cellular levels, detecting, measuring, and visualizing structural characteristics of chemical, biological, and industrial material samples. The company serves customers in life and materials science research, biopharmaceuticals, applied markets, microbiology, in-vitro diagnostics, and nanotechnology. Its technology platforms include magnetic resonance, mass spectrometry, gas and liquid chromatography, X-ray, microscopy, metrology, and molecular spectroscopy. Bruker offers life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, clinical microbiology, and molecular diagnostics. The company's corporate headquarters are in Billerica, Massachusetts, with major technical and manufacturing centers in Europe and North America, and sales offices globally. Bruker has four reportable segments: Bruker Scientific Instruments ("BSI") BioSpin, BSI CALID (Chemicals, Applied Markets, Life Science, In Vitro Diagnostics, Detection), BSI NANO, and Bruker Energy & Supercon Technologies ("BEST"). Products are applied in structural proteomics, drug discovery, pharmaceutical and biotechnology research and production, and food and materials science, helping customers determine the structure, dynamics, and function of specific molecules like proteins to understand biological processes. The BSI BioSpin Segment includes Magnetic Resonance Spectroscopy, offering nuclear magnetic resonance ("NMR") and electron paramagnetic resonance (EPR) products, from benchtop to ultra-high field systems. Magnetic resonance is a natural phenomenon where a molecule in a magnetic field emits a signature radio frequency.